Summit Financial »

Axsome Therapeutics shares owned by Summit Financial

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Summit Financial from 13F filings

Historical chart of Summit Financial investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Summit Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Summit Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.4M 78k 121.45

More positions owned by Summit Financial

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Summit Financial

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Rtw Investments
Macquarie Group
Geode Capital Management
Invesco
State Street Corporation
FMR
Deep Track Capital
Fairmount Funds Management
Eventide Asset Management
Alethea Capital Management
Susquehanna International
OrbiMed Advisors

View all funds holding Axsome Therapeutics